RecruitingNot ApplicableNCT07357259

Delayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer.


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

244 participants

Start Date

Feb 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Recent evidence suggests that both standard-time and delayed-time \[⁶⁸Ga\]Ga-PSMA PET acquisitions can reveal clinically relevant findings, and neither phase should be excluded a priori in routine practice. This study evaluates a streamlined dual-phase protocol consisting of: * A standard whole-body PET/CT acquisition performed 60 minutes after radiotracer administration. * A delayed pelvic PET-only acquisition performed 90 minutes post-injection, reconstructed using the attenuation-correction CT (CT/AC) obtained from the initial whole-body scan. Because the prostate gland and pelvic lymph nodes exhibit minimal physiological mobility, accurate PET-CT anatomical correspondence can be maintained through careful patient repositioning, without repeating the CT scan. The main advantage of this protocol is a reduction in patient radiation exposure, as the delayed phase does not require a second CT scan. It also reduces in-department time and maintains diagnostic quality of PET interpretation, provided that the PET-CT alignment remains acceptable. This method may additionally enhance workflow efficiency in the Nuclear Medicine Unit by allowing early identification-based on predefined clinical parameters-of patients most likely to benefit from delayed pelvic imaging.


Eligibility

Sex: MALEMin Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether taking extra, delayed images during a specialized prostate scan (called a PSMA PET/CT) gives doctors better pictures to find where prostate cancer has spread. **You may be eligible if...** - You have been newly diagnosed with prostate cancer and are getting scans to stage it - Your PSA (a blood marker) has risen again after surgery or radiation therapy for prostate cancer - You have high-risk prostate cancer, meaning your Gleason score is 8 or higher, or your PSA is 20 ng/mL or higher **You may NOT be eligible if...** - You have low- or intermediate-risk prostate cancer - You have other urinary tract problems that could interfere with the scan - You have severe claustrophobia, are very obese, or cannot stay still for the scan - You have a known allergy to the scan's radioactive tracer - You have already participated in this study before Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTIntervention Group

Matching of delayed PET images with the standard CT scan


Locations(1)

IRCCS - Policlinico Universitario di Sant'Orsola

Bologna, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07357259


Related Trials